Left going nuts -Oh no, Trump has financial connection hydroxychloroquine

[jimnyc]

And while many of them are ready for another impeachment, and social media wants to hang him tonight....

I don't think he will get rich off of his $300 but maybe so if the higher estimate of $1,500 is true. :laugh2::laugh2:

Will any of them change their tune, or come back to tell the numbers? Will anyone push forward over his massive connection and soon massive riches? Unfortunately, likely so. With those numbers, I highly doubt he even knows he has anything with them.

[jimnyc]

Fact Check: Trump Does Not Own Stake in a Hydroxychloroquine Drugmaker

Claim: “Donald Trump Has Stake In Hydroxychloroquine Drugmaker: Report”

That’s the headline across a HuffPost story that goes on to claim that “President Donald Trump reportedly owns a stake in a company that produces hydroxychloroquine, the anti-malaria drug he has repeatedly touted as a coronavirus treatment even though his experts say there’s no strong evidence it works.”

Verdict: False.

The report cited by the HuffPost is from a New York Times story that said: “Trump himself has a small personal financial interest in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine.”

Trump’s personal financial interest, however, does not include a stake in Sanofi–and the New York Times did not claim it did. Instead, Trump’s financial disclosures show that his three family trusts each had investments in a $10.3 billion Dodge & Cox mutual fund that owns shares in Sanofi, the world’s fifth-largest drugmaker by prescription sales. As of its latest disclosures, those holdings amount to just 3.3 percent of the fund’s holdings.

Trump’s most recent financial disclosure forms lists holdings in the Dodge & Cox International Fund valued between $1,001 and $15,000. That means Trump holds a maximum stake in the mutual funds of $45,000, giving him an indirect interest in Sanofi of $1,485 at the most.

His “financial interest” in Sanofi, which has a market capitalization of nearly $58 billion, could be as low as $99.10.

This was originally reported by independent journalist Mike Cernovich on his website. Cernovich’s figures are lower because it appears he was calculating the interest of a single trust rather than combining the three trusts as we have here.

Rest - https://www.breitbart.com/economy/2020/04/07/fact-check-trump-does-not-own-stake-in-a-hydroxychloroquine-drugmaker/

[Tyr-Ziu Saxnot]

He is a billionaire that forgoes his Presidential salary(taking none) and the media/dems want to say he profits by advancing the Hydroxychloroquine- drug-- these laughable snips are exactly why smart people see and know what assholes and pure, slimy scum that these hate-filled, ravenously rabid people, so truly are. -Tyr

[jimnyc]

You know it's crap when even Snopes drops it as BS. Before even looking I would imagine that politifact probably says he'll be a trillionaire as a result. :rolleyes:

--

Snopes Gives NYT ‘Mostly False’ Rating Over Article About Trump And Hydroxychloroquine

Snopes fact-checked a New York Times article that argued that President Donald Trump could stand to benefit financially from hydroxychloroquine being used to treat coronavirus patients, deeming the article “mostly false.”

The New York Times published an article Tuesday mentioning the president’s small financial stake Sanofi, a French pharmaceutical company that produces the anti-malaria drug that has shown to be effective in treating the virus. Trump’s personal stake in the company is estimated to be as small as $99. The president’s net worth is estimated to be between 3 and $4 billion.

“Because Trump’s financial interest in Sanofi and other pharmaceutical companies is indirect and minor, and because hydroxychloroquine is an easily produced generic drug unlikely to drive profit, we rank the claim that his promotion of the drug could lead to potential financial benefits as ‘Mostly false,’” the left-leaning fact check outlet wrote.

Rest - https://dailycaller.com/2020/04/08/snopes-new-york-times-hydroxychloroquine-trump-finances-stake-investment/